Literature DB >> 2194140

Intraventricular neurocytoma: a clinical and pathological study of three cases and review of the literature.

M D Barbosa1, M Balsitis, T Jaspan, J Lowe.   

Abstract

Three patients with a recently described tumor of neuronal origin, intraventricular neurocytoma, are presented. These tumors occur as intraventricular lesions in young patients, and the prognosis after surgical treatment is favorable. The initial pathological diagnosis of intraventricular neurocytoma may be difficult because of the striking resemblance of these tumors to oligodendroglioma and, to a lesser extent, ependymoma on light microscopic examination. Despite the use of wide-ranging panels of monoclonal antibodies, previous authors have not found any characteristic immunohistochemical staining patterns, but in our three patients, the use of synaptophysin, glial fibrillary acidic protein, and Leu-7 demonstrated staining patterns that may be useful in the diagnosis of this tumor. The monoclonal antibody Ki-67 was used to stain one tumor and showed a low cell proliferation rate. We have reviewed the clinical, radiological, and pathological features of these 3 patients and 17 previously described patients in an attempt to determine the important diagnostic features of intraventricular neurocytoma. Intraventricular neurocytoma should be considered in any young patient with symptoms of raised intracranial pressure and radiological evidence of an intraventricular lesion. Pathological diagnosis requires the use of electron microscopy to show features of neuronal differentiation; however, immunohistochemical demonstration of a neuronal phenotype is also a useful adjunct to diagnosis. Failure to use specialized techniques for pathological diagnosis will lead to misdiagnosis of these lesions as oligodendrogliomas, as was the initial diagnosis in 2 of our patients before review.

Entities:  

Mesh:

Year:  1990        PMID: 2194140

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

1.  Intraventricular neurocytoma: four cases report.

Authors:  W C Tzaan; Y S Ho; C N Chang; T K Lin; C W Wong
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

2.  Central neurocytoma: a clinical study of response to chemotherapy.

Authors:  D Dodds; J Nonis; M Mehta; R Rampling
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 3.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

Review 4.  Stereotactic radiosurgery for central neurocytoma: a quantitative systematic review.

Authors:  Hyung-ki Park; Chang Steven D
Journal:  J Neurooncol       Date:  2012-05       Impact factor: 4.130

5.  Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination.

Authors:  G Elek; F Slowik; L Eross; S Tóth; Z Szabó; K Bálint
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  Neurocytoma of the retina.

Authors:  C Metcalf; E M Mele; I McAllister
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

7.  Tumours of the lateral ventricle. A retrospective review of 112 cases operated upon 1970-1997.

Authors:  H Z Gökalp; N Yüceer; E Arasil; H Deda; A Attar; A Erdoğan; N Egemen; Y Kanpolat
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

8.  Neurocytoma of spinal cord.

Authors:  S Coca; M Moreno; J A Martos; J Rodriguez; A Barcena; J Vaquero
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Central neurocytoma: its differentiation from intraventricular oligodendroglioma.

Authors:  S T Yuen; C F Fung; T H Ng; S Y Leung
Journal:  Childs Nerv Syst       Date:  1992-10       Impact factor: 1.475

10.  Immunocytochemical detection of calcineurin and microtubule-associated protein 2 in central neurocytoma.

Authors:  S Goto; S Nagahiro; Y Ushio; M Kitaoka; S Nishio; M Fukui
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.